Insider · SEC Form 4 filer

David Hochman

Past buys: 2 of 6 beat

Companies

Where they file as an insider

Orchestra BioMed (OBIO) Officer, Director Latest filing Nov 9, 2026

Track record

Did their buys beat the typical stock?

Open-market buys17
Quarters checked 6 months later6
Beat the typical stock 2 of 6
Quarters too new to check3

2 of 6 checked quarters beat the typical stock. A past record is data, not a forecast.

Orchestra BioMed (OBIO) Bought Nov 9, 2026 · $25K · 5,000 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Orchestra BioMed (OBIO) Bought Sep 3, 2026 · $47.9K · 10,000 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Orchestra BioMed (OBIO) Bought May 15–Jun 1, 2026 · $38K · 10,000 shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.
Orchestra BioMed (OBIO) Bought Mar 13, 2026 · $42.9K · 10,000 shares Beat typical Mar 31, 2026 $4.25 → Sep 30, 2026 $6.22 · +46.4% (typical stock +1.7%)
Orchestra BioMed (OBIO) Bought Nov 14, 2025 · $20.4K · 5,000 shares Behind typical Dec 31, 2025 $4.15 → Jun 30, 2026 $4.32 · +4.0% (typical stock +4.7%)
Orchestra BioMed (OBIO) Bought Aug 4–21, 2025 · $69.9K · 26,000 shares Beat typical Sep 30, 2025 $2.48 → Mar 31, 2026 $4.25 · +71.4% (typical stock −3.4%)
Orchestra BioMed (OBIO) Bought Dec 18–23, 2024 · $43.2K · 9,000 shares Behind typical Dec 31, 2024 $4.00 → Jun 30, 2025 $2.68 · −33.0% (typical stock −3.4%)
Orchestra BioMed (OBIO) Bought Aug 14–Sep 25, 2024 · $62.5K · 12,500 shares Behind typical Sep 30, 2024 $5.14 → Mar 31, 2025 $4.28 · −16.7% (typical stock −7.5%)
Orchestra BioMed (OBIO) Bought Jun 25, 2024 · $6.95K · 1,000 shares Behind typical Jun 30, 2024 $8.15 → Dec 31, 2024 $4.00 · −50.9% (typical stock +3.9%)

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist